Printer Friendly
The Free Library
14,709,470 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

3M Completes Sale of its Pharmaceuticals Business in Europe.


ST. PAUL St. Paul

as a missionary he fearlessly confronts the “perils of waters, of robbers, in the city, in the wilderness.” [N.T.: II Cor. 11:26]

See : Bravery
, Minn. -- 3M (NYSE NYSE

See: New York Stock Exchange
:MMM MMM Myeloid metaplasia with myelofibrosis, see there ) announced today it has completed its transaction with Meda AB for the sale of 3M's pharmaceuticals business in Europe.

Under the agreement, Meda AB will acquire regional marketing and intellectual property rights for 3M's well-known branded pharmaceuticals, including Aldara, Tambocor, MetroGel-Vaginal and Minitran.

The transactions with Ironbridge Capital and Archer Capital for the sale of 3M's pharmaceutical operations in the Asia Pacific region; and Graceway Pharmaceuticals LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
 for the sale of 3M's pharmaceutical operations in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , Canada, and Latin America were completed in the fourth quarter of 2006.

About Meda AB

MEDA AB (publ) is a leading European specialty pharma company that concentrates on marketing and market-adapted product development. Acquisitions and long-term partnerships are fundamental factors that drive the company's strategy. Meda is represented in more than 24 countries and has about 900 employees within marketing and sales. The Meda share is quoted on the OMX OMX Office Max (stock symbol)  Nordic Stock Exchange.

About 3M - A Global, Diversified Technology Company

Every day, 3M people find new ways to make amazing things happen. Wherever they are, whatever they do, the company's customers know they can rely on 3M to help make their lives better. 3M's brands include Scotch, Post-it, Scotchgard, Thinsulate, Scotch-Brite, Filtrete, Command and Vikuiti. Serving customers in more than 200 countries around the world, the people of 3M use their expertise, technologies and global strength to lead in major markets including consumer and office; display and graphics; electronics and telecommunications; safety, security and protection services; health care; industrial and transportation.

Scotch, Post-it, Scotchgard, Thinsulate, Scotch-Brite, Filtrete, Command and Vikuiti are trademarks of 3M.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 2, 2007
Words:268
Previous Article:Alleghany Completes Investment in Homesite Group Incorporated.
Next Article:Lithia Motors Inc. Announces Dividend of $0.14 Per Share for the Fourth Quarter of 2006.
Topics:



Related Articles
Dendrite International announces three-year software and support agreement with 3M U.K.
ALLIANCE COORDINATES PATIENT MEDICAL RECORDS WITH CLINICIANS.(MedicaLogic, Inc and 3M Health Information Systems in licensing deal)(Company Business...
QATAR - LNG Business Expands; Spot Shipments Go To US & Europe.
IVAX/3M Transaction Completed: Respiratory Products Franchise And Sales Force In Europe Expanded.
Dendrite's Business Grows in Europe; New Contracts Signed With Customers in Turkey, Greece, and Italy.
3M to Explore Strategic Alternatives for its Branded Pharmaceuticals Business.
3M Reaches Agreements to Sell its Pharmaceuticals Business.(Company overview)
3M Completes Sale of its Pharmaceuticals Business in Asia Pacific Region.
3M Completes Sale of its Pharmaceuticals Business in the Americas.
Meda AB (publ.) - Q1 2007 Interim Report, January-March.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles